Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) https://validator.w3.org/feed/docs/rss2.html Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) Humanized Antibody Targets Cancer Growth and Spread 3D Cell Models Shed New Light on Cholangiocarcinoma, Offering Hope for Improved Treatments Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE): A Promising Breakthrough for Cholangiocarcinoma Enhancing Cholangiocarcinoma Immunotherapy with Adoptive T Cells Targeting HLA-Restricted Neoantigen Peptides Derived from Driver Gene Mutations Researchers Enhance Peptide Prediction Accuracy for Cancer Immunotherapy Using MD Simulation Arming T Cells to Kill Breast Cancer Cells Role of S100A2 on immune infiltration profiling in colorectal cancer Role of cancer-associated fibroblasts on CAR-T cell function Role of nucleolin as a tumor antigen and immune targeted-therapy Role of gamma delta T cell in colon cancer New Development in Lung Cancer Treatment: High-Affinity Ligand-Based CAR-T Cells Show Promise Against NSCLC Cannabidiol (CBD) Influences Proliferation of CD19-CAR T Cells in Cancer Treatment, New Study Finds Fifth-Generation CAR T Cells Targeting BCMA Show Promise for Multiple Myeloma Treatment Stimulating T Cell Responses Against Patient-Derived Breast Cancer Cells with Neoantigen Peptide-Loaded Peripheral Blood Mononuclear Cells The potential of fourth-generation CAR-T cell therapy in breast cancer Revolutionary Dual-Target CAR T-Cell Therapy Shows Promising Results Against Lymphoma Revolutionary CAR-T Cell Therapy Incorporates IL7 Receptor Alpha to Combat Glioblastoma with Enhanced Antitumor Activity Tri-Specific Killer Engagers (TriKEs): A Promising Multifaceted Immunotherapy Approach for Cancer Treatment Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma Enhancing CAR T-Cell Therapy for Multiple Myeloma: A Third-Generation Approach Targeting BCMA Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia Enhancing T Cell Therapies for Cholangiocarcinoma Using Bispecific T Cell Engager-Armed T Cells Targeting Integrin αvβ6 Engineered Cells Show Promise for Targeted Leukemia Therapy Enhancing Cancer Immunotherapy with Novel Anti-cMET CAR-NK-92 Cells Optimization of anti-TIM3 chimeric antigen receptor with CD8α spacer and TNFR-based costimulation for enhanced efficacy in AML therapy Enhancing T Cell Therapy for Triple-Negative Breast Cancer Enhancing Cancer Immunotherapy with Cordycepin and Cordyceps militaris Extract Enhancing CAR T-Cell Efficacy and Stemness Through Co-stimulation of CD28/CD40 Signaling Molecules Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand Generating T Lymphocytes from Hematopoietic Stem Cells for Cancer Immunotherapy New Humanized Antibody Targets T-Cell Leukemia with Precision Impact of fine particulate matter (PM2.5) on ocular health among people living in Chiang Mai, Thailand Humanized Anti-CD99 Antibody for Targeting T Cell Malignancies Thai Study Links Diet, Gut Microbes, and Lung Cancer Immunotherapy Outcomes Improving Multiple Myeloma Treatment: A New Approach to T Cell Therapy Researchers Develop Method to Remove Specific Problematic Proteins for Improved Drug Effects Enhancing Therapeutic Antibody Design with Computational Tools Optimizing Humanness of Therapeutic Antibodies New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma New Immune Cell Therapy Designed to Improve Treatment for Multiple Myeloma Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study Enhancing T cell cytotoxicity in multiple myeloma with bispecific αPD-L1 × αCD3 T cell engager-armed T cells and low-dose bortezomib therapy New Engineered Immune Cells Show Promise for Treating Difficult-to-Treat Bile Duct Cancer Enhancing T cell cytotoxicity against lung cancer with an αPD-L1 protein engager and gemcitabine combination therapy New Dual-Targeting Protein and Chemotherapy Boost T-Cell Attack on Lung Cancer Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody Efficiently targeting folate receptor alpha-positive ovarian cancer by human antibody VH domain-based chimeric antigen receptor (CAR) Chulalongkorn University Team Kumamoto University